Cell-based therapies, primarily using stem cells, represent a second powerful, mutation-agnostic treatment avenue for Retinitis Pigmentosa that holds the potential for both slowing degeneration and facilitating functional replacement. Researchers are investigating multiple types of stem cells, including induced pluripotent stem cells (iPSCs), embryonic stem cells, and adult stem cells (such as...